Date(s) - April 28, 2021
1:00 pm - 2:15 pm
Categories No Categories
About this Event
This is a two-webinar series that brings Christian bioethics to bear on CRISPR-Cas9, a revolutionary technology that enables geneticists to alter parts of the genome by removing, adding, or altering sections of the DNA sequence. While genome-editing technology could allow for genetic changes that cure disease or have other positive effects, it also raises significant ethical and theological questions.
The first webinar, on March 31, will look at the science behind CRISPR-Cas9, how the technology functions, and how the technology is currently being used.
The second part, on April 28, 2021, will examine from a historical perspective the question of who gets to control and apply genome editing and other ethical and theological conflicts the new technology raises.
This event will be held in English only and is intended for both experts and non-experts who wish to reflect ethically and theologically about the potential risks and benefits of gene editing. This event will be held in English only and is intended for both experts and non-experts who wish to reflect ethically and theologically about the potential risks and benefits of gene editing.
Presenter: Dr. James Rusthoven, Professor Emeritus, Dept. Of Oncology, McMaster University, Retired Medical Oncologist and Medical Officer- Health Canada
- Wed. March 31, 2021 | 4pm – 5pm EST: “What could CRISPR-Cas9 mean for human flourishing?”
- Wed. Apr. 28, 2021 at 4 – 5:15 PM EST: “Who will determine the course of human genome editing?”